Hamilton, D.J.; Ábrányi-Balogh, P.; Keeley, A.; Petri, L.; Hrast, M.; Imre, T.; Wijtmans, M.; Gobec, S.; Esch, I.J.P.d.; Keserű, G.M.
Bromo-Cyclobutenaminones as New Covalent UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors. Pharmaceuticals 2020, 13, 362.
https://doi.org/10.3390/ph13110362
AMA Style
Hamilton DJ, Ábrányi-Balogh P, Keeley A, Petri L, Hrast M, Imre T, Wijtmans M, Gobec S, Esch IJPd, Keserű GM.
Bromo-Cyclobutenaminones as New Covalent UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors. Pharmaceuticals. 2020; 13(11):362.
https://doi.org/10.3390/ph13110362
Chicago/Turabian Style
Hamilton, David J., Péter Ábrányi-Balogh, Aaron Keeley, László Petri, Martina Hrast, Tímea Imre, Maikel Wijtmans, Stanislav Gobec, Iwan J. P. de Esch, and György Miklós Keserű.
2020. "Bromo-Cyclobutenaminones as New Covalent UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors" Pharmaceuticals 13, no. 11: 362.
https://doi.org/10.3390/ph13110362
APA Style
Hamilton, D. J., Ábrányi-Balogh, P., Keeley, A., Petri, L., Hrast, M., Imre, T., Wijtmans, M., Gobec, S., Esch, I. J. P. d., & Keserű, G. M.
(2020). Bromo-Cyclobutenaminones as New Covalent UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors. Pharmaceuticals, 13(11), 362.
https://doi.org/10.3390/ph13110362